Search research articles
Contact Us
Filters
Showing results (41-50 of 178) with videos related to
Page
of 18
Sort By:
Communications Biology
|
October 1, 2025
Long non-coding RNAs as a biomarker for homologous recombination deficiency and parp inhibitor sensitivity in high-grade serous ovarian cancers
Kai Doberstein, Johannes Panther, Eric Hahnen, et al.
Gynecologic Oncology
|
January 26, 2016
Operability and chemotherapy responsiveness in advanced low-grade serous ovarian cancer. An analysis of the AGO Study Group metadatabase
Jacek P Grabowski, Philipp Harter, Florian Heitz, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
October 31, 2018
Uterine and Tubal Lavage for Earlier Cancer Detection Using an Innovative Catheter: A Feasibility and Safety Study
Elisabeth Maritschnegg, Florian Heitz, Nina Pecha, et al.
Geburtshilfe Und Frauenheilkunde
|
October 29, 2019
Impact of Nuclear Oestrogen Receptor Beta Expression in Breast Cancer Patients Undergoing Neoadjuvant Chemotherapy
Florian Heitz, Sherko Kümmel, Bianca Lederer, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
December 15, 2020
A phase III, randomized, double blinded trial of platinum based chemotherapy with or without atezolizumab followed by niraparib maintenance with or without atezolizumab in patients with recurrent ovarian, tubal, or peritoneal cancer and platinum treatment free interval of more than 6 months: ENGOT-Ov41/GEICO 69-O/ANITA Trial
Antonio Gonzalez Martin, Luisa Sanchez Lorenzo, Nicoletta Colombo, et al.
Gynecologic Oncology
|
October 15, 2023
Low anterior resection syndrome and its impact on quality of life of ovarian carcinoma patients: A prospective longitudinal study
Majdi Imterat, Gudrun Gebers, Florian Heitz, et al.
Archives of Gynecology and Obstetrics
|
February 15, 2020
Sentinel lymph node mapping with fluorescent and radioactive tracers in vulvar cancer patients
Sonia Prader, Andreas du Bois, Philipp Harter, et al.
Geburtshilfe Und Frauenheilkunde
|
September 9, 2020
Prevalence of <i>BRCA1</i> and <i>BRCA2</i> Mutations in Patients with Primary Ovarian Cancer - Does the German Checklist for Detecting the Risk of Hereditary Breast and Ovarian Cancer Adequately Depict the Need for Consultation?
Beyhan Ataseven, Denise Tripon, Kerstin Rhiem, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
October 18, 2025
Cytoreductive surgery for recurrent platinum-sensitive low-grade ovarian carcinoma: a retrospective single institution experience
Maximilian Pruss, Mareike Bommert, Sarah Ehmann, et al.
Gynecologic Oncology
|
March 3, 2020
Fertility-sparing surgery and reproductive-outcomes in patients with borderline ovarian tumors
Helmut Plett, Philipp Harter, Beyhan Ataseven, et al.
Page
of 18
Search research articles
Search
Showing results (41-50 of 178) with videos related to
Sort By:
Page
of 18
Communications Biology
|
October 1, 2025
Long non-coding RNAs as a biomarker for homologous recombination deficiency and parp inhibitor sensitivity in high-grade serous ovarian cancers
Kai Doberstein, Johannes Panther, Eric Hahnen, et al.
Gynecologic Oncology
|
January 26, 2016
Operability and chemotherapy responsiveness in advanced low-grade serous ovarian cancer. An analysis of the AGO Study Group metadatabase
Jacek P Grabowski, Philipp Harter, Florian Heitz, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
October 31, 2018
Uterine and Tubal Lavage for Earlier Cancer Detection Using an Innovative Catheter: A Feasibility and Safety Study
Elisabeth Maritschnegg, Florian Heitz, Nina Pecha, et al.
Geburtshilfe Und Frauenheilkunde
|
October 29, 2019
Impact of Nuclear Oestrogen Receptor Beta Expression in Breast Cancer Patients Undergoing Neoadjuvant Chemotherapy
Florian Heitz, Sherko Kümmel, Bianca Lederer, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
December 15, 2020
A phase III, randomized, double blinded trial of platinum based chemotherapy with or without atezolizumab followed by niraparib maintenance with or without atezolizumab in patients with recurrent ovarian, tubal, or peritoneal cancer and platinum treatment free interval of more than 6 months: ENGOT-Ov41/GEICO 69-O/ANITA Trial
Antonio Gonzalez Martin, Luisa Sanchez Lorenzo, Nicoletta Colombo, et al.
Gynecologic Oncology
|
October 15, 2023
Low anterior resection syndrome and its impact on quality of life of ovarian carcinoma patients: A prospective longitudinal study
Majdi Imterat, Gudrun Gebers, Florian Heitz, et al.
Archives of Gynecology and Obstetrics
|
February 15, 2020
Sentinel lymph node mapping with fluorescent and radioactive tracers in vulvar cancer patients
Sonia Prader, Andreas du Bois, Philipp Harter, et al.
Geburtshilfe Und Frauenheilkunde
|
September 9, 2020
Prevalence of <i>BRCA1</i> and <i>BRCA2</i> Mutations in Patients with Primary Ovarian Cancer - Does the German Checklist for Detecting the Risk of Hereditary Breast and Ovarian Cancer Adequately Depict the Need for Consultation?
Beyhan Ataseven, Denise Tripon, Kerstin Rhiem, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
October 18, 2025
Cytoreductive surgery for recurrent platinum-sensitive low-grade ovarian carcinoma: a retrospective single institution experience
Maximilian Pruss, Mareike Bommert, Sarah Ehmann, et al.
Gynecologic Oncology
|
March 3, 2020
Fertility-sparing surgery and reproductive-outcomes in patients with borderline ovarian tumors
Helmut Plett, Philipp Harter, Beyhan Ataseven, et al.
Page
of 18